drugset

drugset / Trial / NCT07231965

Synthetic THC And Blood Pressure

NCT07231965 ↗

Phase 2/3 Not yet recruiting 50 enrolled Mayo Clinic

RandomizedCrossoverDouble-blindTreatment

Summary

To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology

Timeline

Start: 2026-07
Primary completion: 2027-12
Completion: 2027-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Dronabinol	Other / unclassified	10 mg	—

Indications